Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03449381
Title This Study Aims to Find the Best Dose of BI 907828 in Patients With Different Types of Advanced Cancer (Solid Tumors)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Boehringer Ingelheim



lung non-squamous non-small cell carcinoma

Advanced Solid Tumor

transitional cell carcinoma


BI 907828

Age Groups: adult | senior
Covered Countries USA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Yale University School of Medicine Recruiting New Haven Connecticut 06511 United States Details
Florida Cancer Specialists Recruiting Sarasota Florida 34232 United States Details
Memorial Sloan-Kettering Cancer Center Recruiting New York New York 10065 United States Details
Tennessee Oncology, PLLC Recruiting Nashville Tennessee 37203 United States Details
UZ Leuven Recruiting Leuven 3000 Belgium Details
The Ottawa Hospital Recruiting Ottawa Ontario K1H 8L6 Canada Details
Helios Klinikum Berlin-Buch Recruiting Berlin 13125 Germany Details
Universitätsklinikum Köln (AöR) Recruiting Köln 50937 Germany Details
Universitätsklinikum Tübingen Recruiting Tübingen 72076 Germany Details
National Cancer Center Hospital Recruiting Tokyo, Chuo-ku 104-0045 Japan Details
MED POLONIA SP Z O O, Clinical Trials Department,Poznan Recruiting Poznan 60-693 Poland Details
Oncology Center-Maria Sklodowska-Curie Institute Recruiting Warsaw 02-034 Poland Details
Hospital Vall d'Hebron Recruiting Barcelona 08035 Spain Details
Hospital Clínic de Barcelona Recruiting Barcelona 08036 Spain Details
*Shaded cells indicate that there was no data available from for the field